# Phathom Pharmaceuticals Inc. (PHAT) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$160M |
| 2024 | -$277M |
| 2023 | -$167M |
| 2022 | -$172M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$15M |
| 2025-09-30 | -$15M |
| 2025-06-30 | -$60M |
| 2025-03-31 | -$79M |
| 2024-09-30 | -$71M |
| 2024-06-30 | -$77M |
| 2024-03-31 | -$70M |
| 2023-09-30 | -$36M |
| 2023-06-30 | -$32M |
| 2023-03-31 | -$30M |

Source: [CompaniesByCap](https://companiesbycap.com/company/PHAT/operating-income)